INTRODUCTION
In recent years a significant development occurs in the study of cancer diseases in animals and especially in dogs. The reasons that lead to the appearance of tumors in dogs are (1) those associated with the occurrence of tumors in farm animals, often worn by the character of widespread, requiring the adoption of appropriate measures, based on scientific research, and (2) increased interest in problems comparing tumors in humans and domestic animals, as the latter the "model" in the study of human tumors and significant role in the expansion of knowledge about the nature of tumor growth providing appropriate care in the treatment of tumor development (Gardner et al., 2015) . It should be noted that according to the scientific and experimental studies, dogs have the same sensitivity to carcinogens as gas pollution, ionizing radiation, solar radiation etc. Furthermore, tumors in dogs develop after the start of exposure to carcinogens much faster than in man. With this in mind, as well as the fact that dogs live in the same environment, and often eat the same food, drink the same water as the man a study of tumors for early detection of possible human carcinogen environmental factors is quite urgent. Identifying similarities in development of certain tumors in dogs and humans can be considered as natural models and can be used for study of the development of human tumor, their diagnosis and the development of new treatments. The problem of immunological reactivity in tumor growth remains one of the most important scientific problems of modern medicine and veterinary medicine. The promise of pharmaceutical biotechnology and its applications to health care is now being realized. Therapeutic agents produced by the tools of biotechnology are now available. Recombinant proteins, monoclonal antibodies, gene therapy, and vaccines can provide effective treatments and cures for diseases we could only mitigate in the past. The availability of these drugs presents several interesting challenges and opportunities to pharmacists. The expense, complexity, and unique properties of biotechnology agents will continue to alter not only the knowledge base of pharmacy but also the way pharmacists perform their professional responsibilities (Piascik, 1998) .
Aim of study was to analyze the effect of levamisole and BCG on selected immunological and hematological parameters in dogs with cancer pathologies.
MATERIAL AND METHODS
In this study dogs with tumors of the breast, received at the Department of Anatomy, Physiology, Surgery and Pharmacology of Animals, Samarkand Agricultural Institute were analyzed. From 150 dogs examined breast tumor of various sizes was detected in 45 cases. Dogs were divided into 3 groups: 2 experimental and control. All dogs were subjected to surgical intervention to remove breast cancer. In the first experimental group (E1) dogs received levamisole (intramuscular 75 mg two injections a week); in the second experimental group (E2) Bacillus CalmetteGuerin (BCG, subcutaneously 0.5 mg once per week). The third group served as a control in which only the surgical removal of the tumor was realized. For general anesthesia i.v. 2.5% solution of chlorpromazine (1 ml per 10 kg body weight), 5% ketamine (1 ml), and in some cases for complete relaxation intramuscular injection of 2% xyla (0.15 ml per 10 kg body weight) was used. For local anesthesia 0.5% novocain solution was used, injected between the skin and the capsule of the tumor. After each injection the blood was analyzed for hemoglobin, erythrocytes, leukocytes and leukocyte formula by conventional methods, T-and Blymphocytes were determined by plaque assay. Diagnosis was based on clinical and histological studies. Clinical examination included an assessment of the primary tumor sites, regional lymph nodes, and the general condition of the animal.
RESULTS AND DISCUSSION
For removing the breast tumor straight-line or spindle-shaped incision was used, depending on the size of the tumor. After making the skin incision blunt was capable for skin separation from the tumor capsule. It was necessary to stop the bleeding during the operation mechanically. After removal of the breast tumor performed skin grafting was done and interrupted skin sutures were applied. In cases of metastasis in the regional lymph nodes they were also removed. Sutures were removed on day 7-10. In the first group (E1) with levamisole application the level of T-lymphocytes before the therapy was 38.3±2.6% after the applications 53.3±0.3% of white blood cells (277.4±0.6 vs. 1271.5±0.8 per µl). The level of B-lymphocytes was before therapy 4.3±0.3% and after the therapy reached 15.7±1.0% (31.6±0.8 vs. 374.2±1.5 per µl). For subpopulation of T-lymphocytes the relative occurrence of T-helper cells was 26.6±1.6% vs. 36.3±1.6% and T-suppressors 7.6±0.1% vs. 8.0±0.6% after therapy (Figure 1 ). Generally cancer suppresses the immune system. In the investigation of immunotherapy to blood in dogs a decrease of lymphocyte to 6-8% was observed. After removal of tumors in dogs the immune system was stimulated in groups with BCG and levamisole application. Cytological or histological examination of tissue is usually used for tumor identification. Instrumental methods as X-ray or ultrasound are used to find distant nodal or hematogenous metastases. Clinical signs of breast cancer are paraneoplastical syndromes (Piane et al., 2014) , which usually do not develop immediately and strongly time lag in the development of the visible changes of the breast configuration. Deformation can form single or multiple units of various sizes, texture, density, with or without cysts affecting one or more packets of the breast, often painful, but sometimes accompanied by pain and signs of inflammation with broken or intact skin over the deformation (Lim et al., 2015) . Morphological (cytological and histological) diagnosis of tumors of the mammary glands is required for the following tasks -differential diagnosis of breast tumors from benign diseases, identification of breast cancer to develop tactics for further diagnostic and therapeutic measures, determination of the histological characteristics of the tumor (type, germination of the capsule, the degree of malignancy) for the development of operational tactics after the treatment and control of metastasis and prognosis of outcomes, morphological study of regional lymph nodes for detection of nodal metastases as well as cytology performed to detect cancer cells by aspiration or biopsy (Munson and  Moresco, 2007; Klopfleisch et al., 2011) . Immuno-biological studies of the interaction of organisms with tumor cells and tissues show that the determining factor in the prevention of the emergence and development in the effective elimination of tumor cells is the stimulation of both specific and non-specific defense systems of the body and immune system as a whole (Eifel et al. 2001) . It is also known that the most important are the problems of cancer therapy. It was found that many drugs and methods for treating tumors give quite good results, even in the treatment of experimental tumors were unsuitable or quite effective in the treatment of spontaneous animal and human tumors. That is why the use of affected animals with spontaneously occurring tumors seems more promising to clarify many issues genesis blastoma process research to develop effective treatments for tumors of humans and animals ( The most effective treatment is the biophysical and/or biochemical processes against pathological processes that lead to disease. However, the study of the phenomenon known as "the body's resistance" is the first step. Significant theoretical advance in oncology was the discovery that cancer is caused by a specific immune response in the body, in which it appears (Brtitta et al. 
